Shares of Seer, Inc. (NASDAQ:SEER - Get Free Report) were up 1.4% on Friday . The company traded as high as $2.28 and last traded at $2.24. Approximately 56,239 shares were traded during trading, a decline of 80% from the average daily volume of 280,900 shares. The stock had previously closed at $2.21.
Seer Stock Down 0.5%
The firm has a market cap of $127.75 million, a P/E ratio of -1.54 and a beta of 1.57. The business's 50 day moving average is $2.06 and its 200-day moving average is $2.10.
Seer (NASDAQ:SEER - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.03. Seer had a negative net margin of 560.90% and a negative return on equity of 24.69%. The company had revenue of $4.21 million during the quarter, compared to the consensus estimate of $3.25 million. As a group, equities analysts predict that Seer, Inc. will post -1.42 earnings per share for the current year.
Insider Buying and Selling at Seer
In related news, Director Dipchand Nishar sold 30,253 shares of the firm's stock in a transaction on Friday, June 13th. The stock was sold at an average price of $2.08, for a total transaction of $62,926.24. Following the transaction, the director directly owned 49,204 shares in the company, valued at $102,344.32. This trade represents a 38.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 11.28% of the company's stock.
Institutional Trading of Seer
A number of institutional investors and hedge funds have recently modified their holdings of the business. Goldman Sachs Group Inc. grew its position in shares of Seer by 51.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 170,897 shares of the company's stock valued at $289,000 after buying an additional 58,173 shares during the last quarter. Jane Street Group LLC boosted its stake in Seer by 33.3% in the first quarter. Jane Street Group LLC now owns 254,174 shares of the company's stock valued at $430,000 after acquiring an additional 63,432 shares during the period. Jacobs Levy Equity Management Inc. grew its holdings in shares of Seer by 124.5% during the first quarter. Jacobs Levy Equity Management Inc. now owns 363,355 shares of the company's stock valued at $614,000 after purchasing an additional 201,491 shares during the last quarter. OMERS ADMINISTRATION Corp grew its holdings in shares of Seer by 54.3% during the first quarter. OMERS ADMINISTRATION Corp now owns 76,200 shares of the company's stock valued at $129,000 after purchasing an additional 26,819 shares during the last quarter. Finally, Two Sigma Advisers LP raised its position in shares of Seer by 24.2% during the 4th quarter. Two Sigma Advisers LP now owns 681,900 shares of the company's stock worth $1,575,000 after purchasing an additional 132,800 shares during the period. 75.20% of the stock is owned by institutional investors and hedge funds.
Seer Company Profile
(
Get Free Report)
Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Recommended Stories
Before you consider Seer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Seer wasn't on the list.
While Seer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.